TempraMed Secures Global Breakthrough: Partnership with Israel’s 2.8 M‑Member Maccabi HMO
TempraMed’s new deal with Israel’s Maccabi HMO shows its temperature‑control drugs can scale worldwide, opening a 2.8 M‑member market and boosting global growth.
2 minutes to read